These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 31240269)

  • 1. Redox Signaling in Sickle Cell Disease.
    Nolfi-Donegan D; Pradhan-Sundd T; Pritchard KA; Hillery CA
    Curr Opin Physiol; 2019 Jun; 9():26-33. PubMed ID: 31240269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Control of Oxidative Stress and Inflammation in Sickle Cell Disease with the Nrf2 Activator Dimethyl Fumarate.
    Belcher JD; Chen C; Nguyen J; Zhang P; Abdulla F; Nguyen P; Killeen T; Xu P; O'Sullivan G; Nath KA; Vercellotti GM
    Antioxid Redox Signal; 2017 May; 26(14):748-762. PubMed ID: 26914345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heme triggers TLR4 signaling leading to endothelial cell activation and vaso-occlusion in murine sickle cell disease.
    Belcher JD; Chen C; Nguyen J; Milbauer L; Abdulla F; Alayash AI; Smith A; Nath KA; Hebbel RP; Vercellotti GM
    Blood; 2014 Jan; 123(3):377-90. PubMed ID: 24277079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haptoglobin and hemopexin inhibit vaso-occlusion and inflammation in murine sickle cell disease: Role of heme oxygenase-1 induction.
    Belcher JD; Chen C; Nguyen J; Abdulla F; Zhang P; Nguyen H; Nguyen P; Killeen T; Miescher SM; Brinkman N; Nath KA; Steer CJ; Vercellotti GM
    PLoS One; 2018; 13(4):e0196455. PubMed ID: 29694434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Worst Things in Life are Free: The Role of Free Heme in Sickle Cell Disease.
    Gbotosho OT; Kapetanaki MG; Kato GJ
    Front Immunol; 2020; 11():561917. PubMed ID: 33584641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic Overexpression of Hemopexin Inhibits Inflammation and Vascular Stasis in Murine Models of Sickle Cell Disease.
    Vercellotti GM; Zhang P; Nguyen J; Abdulla F; Chen C; Nguyen P; Nowotny C; Steer CJ; Smith A; Belcher JD
    Mol Med; 2016 Sep; 22():437-451. PubMed ID: 27451971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. H-ferritin ferroxidase induces cytoprotective pathways and inhibits microvascular stasis in transgenic sickle mice.
    Vercellotti GM; Khan FB; Nguyen J; Chen C; Bruzzone CM; Bechtel H; Brown G; Nath KA; Steer CJ; Hebbel RP; Belcher JD
    Front Pharmacol; 2014; 5():79. PubMed ID: 24860503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haptoglobin attenuates hemoglobin-induced heme oxygenase-1 in renal proximal tubule cells and kidneys of a mouse model of sickle cell disease.
    Chintagari NR; Nguyen J; Belcher JD; Vercellotti GM; Alayash AI
    Blood Cells Mol Dis; 2015 Mar; 54(3):302-6. PubMed ID: 25582460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Red Blood Cell-Inflammation Vicious Circle in Sickle Cell Disease.
    Nader E; Romana M; Connes P
    Front Immunol; 2020; 11():454. PubMed ID: 32231672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human sickle cell blood modulates endothelial heme oxygenase activity: effects on vascular adhesion and reactivity.
    Bains SK; Foresti R; Howard J; Atwal S; Green CJ; Motterlini R
    Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):305-12. PubMed ID: 19965783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amelioration of inflammation and tissue damage in sickle cell model mice by Nrf2 activation.
    Keleku-Lukwete N; Suzuki M; Otsuki A; Tsuchida K; Katayama S; Hayashi M; Naganuma E; Moriguchi T; Tanabe O; Engel JD; Imaizumi M; Yamamoto M
    Proc Natl Acad Sci U S A; 2015 Sep; 112(39):12169-74. PubMed ID: 26371321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triterpenoid inducers of Nrf2 signaling as potential therapeutic agents in sickle cell disease: a review.
    Owusu-Ansah A; Choi SH; Petrosiute A; Letterio JJ; Huang AY
    Front Med; 2015 Mar; 9(1):46-56. PubMed ID: 25511620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathophysiology of Sickle Cell Disease.
    Sundd P; Gladwin MT; Novelli EM
    Annu Rev Pathol; 2019 Jan; 14():263-292. PubMed ID: 30332562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heme oxygenase-1 gene delivery by Sleeping Beauty inhibits vascular stasis in a murine model of sickle cell disease.
    Belcher JD; Vineyard JV; Bruzzone CM; Chen C; Beckman JD; Nguyen J; Steer CJ; Vercellotti GM
    J Mol Med (Berl); 2010 Jul; 88(7):665-75. PubMed ID: 20306336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sickle Cell Disease: Role of Oxidative Stress and Antioxidant Therapy.
    Vona R; Sposi NM; Mattia L; Gambardella L; Straface E; Pietraforte D
    Antioxidants (Basel); 2021 Feb; 10(2):. PubMed ID: 33669171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depletion of haptoglobin and hemopexin promote hemoglobin-mediated lipoprotein oxidation in sickle cell disease.
    Yalamanoglu A; Deuel JW; Hunt RC; Baek JH; Hassell K; Redinius K; Irwin DC; Schaer DJ; Buehler PW
    Am J Physiol Lung Cell Mol Physiol; 2018 Nov; 315(5):L765-L774. PubMed ID: 30047285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma-Derived Hemopexin as a Candidate Therapeutic Agent for Acute Vaso-Occlusion in Sickle Cell Disease: Preclinical Evidence.
    Gentinetta T; Belcher JD; Brügger-Verdon V; Adam J; Ruthsatz T; Bain J; Schu D; Ventrici L; Edler M; Lioe H; Patel K; Chen C; Nguyen J; Abdulla F; Zhang P; Wassmer A; Jain M; Mischnik M; Pelzing M; Martin K; Davis R; Didichenko S; Schaub A; Brinkman N; Herzog E; Zürcher A; Vercellotti GM; Kato GJ; Höbarth G
    J Clin Med; 2022 Jan; 11(3):. PubMed ID: 35160081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemopexin dosing improves cardiopulmonary dysfunction in murine sickle cell disease.
    Buehler PW; Swindle D; Pak DI; Ferguson SK; Majka SM; Karoor V; Moldovan R; Sintas C; Black J; Gentinetta T; Buzzi RM; Vallelian F; Wassmer A; Edler M; Bain J; Schu D; Hassell K; Nuss R; Schaer DJ; Irwin DC
    Free Radic Biol Med; 2021 Nov; 175():95-107. PubMed ID: 34478834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous infusion of haptoglobin for the prevention of adverse clinical outcome in Sickle Cell Disease.
    Quimby KR; Hambleton IR; Landis RC
    Med Hypotheses; 2015 Oct; 85(4):424-32. PubMed ID: 26141635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HO-1
    Liu Y; Jing F; Yi W; Mendelson A; Shi P; Walsh R; Friedman DF; Minniti C; Manwani D; Chou ST; Yazdanbakhsh K
    Blood; 2018 Apr; 131(14):1600-1610. PubMed ID: 29437594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.